ULIHF (United Laboratories International Holdings) Enterprise Value: $1,505 Mil (As of Jul. 16, 2026) ***

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ULIHF United Laboratories International Holdings Ltd ULIHF
80 GF Score
Price $1.24
GF Value $1.43
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings Enterprise Value?

United Laboratories International Holdings ULIHF 80 Enterprise Value is $1,505 Mil as of Jul. 16, 2026. GuruFocus rates ULIHF with a GF Score™ of 80/100 and a GF Value™ of $1.43 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, United Laboratories International Holdings's Enterprise Value is $1,505 Mil. United Laboratories International Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $362 Mil. Therefore, United Laboratories International Holdings's EV-to-EBIT ratio for today is 4.15.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, United Laboratories International Holdings's Enterprise Value is $1,505 Mil. United Laboratories International Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $454 Mil. Therefore, United Laboratories International Holdings's EV-to-EBITDA ratio for today is 3.32.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, United Laboratories International Holdings's Enterprise Value is $1,505 Mil. United Laboratories International Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $1,855 Mil. Therefore, United Laboratories International Holdings's EV-to-Revenue ratio for today is 0.81.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, United Laboratories International Holdings's Enterprise Value is $1,505 Mil. United Laboratories International Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $527 Mil. Therefore, United Laboratories International Holdings's EV-to-OCF ratio for today is 2.86.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, United Laboratories International Holdings's Enterprise Value is $1,505 Mil. United Laboratories International Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $121 Mil. Therefore, United Laboratories International Holdings's EV-to-FCF ratio for today is 12.47.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


United Laboratories International Holdings  (OTCPK:ULIHF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

United Laboratories International Holdings's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1504.929/362.2
=4.15

United Laboratories International Holdings's current Enterprise Value is $1,505 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $362 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

United Laboratories International Holdings's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1504.929/453.578
=3.32

United Laboratories International Holdings's current Enterprise Value is $1,505 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $454 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

United Laboratories International Holdings's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1504.929/1855.259
=0.81

United Laboratories International Holdings's current Enterprise Value is $1,505 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $1,855 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

United Laboratories International Holdings's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=1504.929/526.985
=2.86

United Laboratories International Holdings's current Enterprise Value is $1,505 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $527 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

United Laboratories International Holdings's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1504.929/120.725
=12.47

United Laboratories International Holdings's current Enterprise Value is $1,505 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $121 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings Enterprise Value Related Terms


United Laboratories International Holdings Enterprise Value Historical Data

* Premium members only.

The historical data trend for United Laboratories International Holdings's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Laboratories International Holdings Enterprise Value Chart

United Laboratories International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 876.03 612.34 1,238.82 1,841.77 2,913.94

United Laboratories International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,238.82 1,422.32 1,841.77 2,826.36 2,913.94

ULIHF vs ZTS, UTHR: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Enterprise Value falls into.


ULIHF
80GF Score
United Laboratories International Holdings Ltd ULIHF
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

United Laboratories International Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

United Laboratories International Holdings's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

United Laboratories International Holdings's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of $1,505 Mil mean?
United Laboratories International Holdings (ULIHF) has a Enterprise Value of $1,505 Mil as of Jul. 16, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on United Laboratories International Holdings and its competitors.
Is United Laboratories International Holdings' Enterprise Value too high?
United Laboratories International Holdings' current Enterprise Value is $1,505 Mil. Overall, United Laboratories International Holdings has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' Enterprise Value compare to ZTS and UTHR?
United Laboratories International Holdings' Enterprise Value of $1,505 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on United Laboratories International Holdings and its competitors. United Laboratories International Holdings's current Enterprise Value is $1,505 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
Based on GuruFocus' analysis, United Laboratories International Holdings (ULIHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.43, compared to a current price of $1.24 — trading 13.3% below its estimated fair value. The current Enterprise Value is $1,505 Mil. United Laboratories International Holdings' overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For United Laboratories International Holdings (ULIHF), the current Enterprise Value is $1,505 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Laboratories International Holdings (ULIHF) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be undervalued. The current stock price of $1.24 is trading 13.3% below its estimated GF Value™ of $1.43. GuruFocus considers United Laboratories International Holdings to be Modestly Undervalued.

Key valuation signals for ULIHF:

  • Enterprise Value: $1,505 Mil
  • GF Value™: $1.43 vs. price of $1.24 (13.3% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the ULIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


United Laboratories International Holdings Business Description

Other Exchanges 03933:Hong KongUNJ:Germany
Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
80GF Score

Get the complete analysis for ULIHF

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.24
Price
$1.43
GF Value